| 1 | [SID24386759] | Active | Potency | 10 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table | |
|
| 2 | [SID24386759] | Active | Potency | 10 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] | View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table | |
|
| 3 | [SID24386759] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table | |
|
| 4 | [SID24386759] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table | |
|
| 5 | [SID24386759] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table | |
|
| 6 | [SID24386759] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table | |
|
| 7 | [SID24386759] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table | |
|
| 8 | [SID24386759] | Active | Potency | 20.5749 | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen [AID686980, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 20.5749 [uM] | | BioAssay | qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen | | AID | 686980 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table | |
|
| 9 | [SID24386759] | Active | Potency | 22.9273 | qHTS Confirmation Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2585, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 22.9273 [uM] | | BioAssay | qHTS Confirmation Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2585 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table | |
|
| 10 | [SID24386759] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table | |
|
| 11 | [SID24386759] | Active | Potency | 28.1838 | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table | |
|
| 12 | [SID24386759] | Active | Potency | 89.1251 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Active | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table | |
|
| 13 | [SID24386759] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 14 | [SID24386759] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 15 | [SID24386759] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 16 | [SID24386759] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 17 | [SID24386759] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 18 | [SID24386759] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 19 | [SID24386759] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 20 | [SID96121811] | Inactive | | | A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in Staphylococcus aureus [AID463173, Type: screening] | | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 96121811 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in Staphylococcus aureus | | AID | 463173 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table | |
|
| 21 | [SID96121811] | Inactive | | | A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in Staphylococcus aureus [AID463173_1, Type: screening] | | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 96121811 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in Staphylococcus aureus | | AID | 463173 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table | |
|
| 22 | [SID96121811] | Inactive | | | A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in Staphylococcus aureus [AID463173_2, Type: screening] | | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 96121811 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit cell wall-associated teichoic acid synthesis in Staphylococcus aureus | | AID | 463173 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table | |
|
| 23 | [SID24386759] | Inactive | Potency | | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1463, Type: confirmatory] | | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1463 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 24 | [SID24386759] | Inactive | Potency | | Quantitative High-Throughput Screen for Regulators of Epigenetic Control [AID1865, Type: confirmatory] | | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Quantitative High-Throughput Screen for Regulators of Epigenetic Control | | AID | 1865 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 25 | [SID24386759] | Inactive | Potency | | qHTS Assay for Compounds that Induce Erasure of Genomic Imprints [AID1948, Type: confirmatory] | | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Compounds that Induce Erasure of Genomic Imprints | | AID | 1948 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 26 | [SID24386759] | Inactive | Potency | | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 27 | [SID24386759] | Inactive | Potency | | qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 [AID2289, Type: confirmatory] | | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 | | AID | 2289 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 28 | [SID24386759] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 29 | [SID24386759] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table | |
|
| 30 | [SID24386759] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table | |
|
| 31 | [SID24386759] | Inactive | Potency | | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table | |
|
| 32 | [SID24386759] | Inactive | Potency | | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table | |
|
| 33 | [SID24386759] | Inactive | Potency | | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table | |
|
| 34 | [SID24386759] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 35 | [SID24386759] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 36 | [SID24386759] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 37 | [SID24386759] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 38 | [SID24386759] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 39 | [SID24386759] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 40 | [SID24386759] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 41 | [SID24386759] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 42 | [SID24386759] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 43 | [SID24386759] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table | |
|
| 44 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
| 45 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
| 46 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
| 47 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
| 48 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
| 49 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
| 50 | [SID24386759] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] | View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24386759 | | CID | 16010245 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
